glp-1 diet pills vs. Shots: Which Is Easier, Cheaper, and More Effective for Weight Loss? The first ever FDA-approved GLP-1

EMPA-KIDNEY: expanding the range of kidney protection by SGLT2 inhibitors

Continuation of Therapy If a patient is already taking a GLP-1 medication but changes insurance plans , the prior authorization can often be submitted as: Continuation of therapy Helpful documentation may include: current medication and dose duration of therapy prior weight or A1C response In some cases, continuation of therapy documentation may help bypass step therapy requirements

From clinical studies and real-world experience, general patterns often look like this: First 48 weeks: Appetite starts to calm down

Open 8 , e2521887 (2025)

The combination of metformin and a GLP-1 agonist is a common pairing in type 2 diabetes management, reflecting the polypharmacy strategy I described earlier: two different mechanisms, two different targets, and lower doses of each